Autor: |
B S, Kibrik, A V, Pavlov, O G, Chelnokova |
Rok vydání: |
2013 |
Předmět: |
|
Zdroj: |
Eksperimental'naia i klinicheskaia farmakologiia. 76(2) |
ISSN: |
0869-2092 |
Popis: |
The antituberculosis effect of tubosan registered in the Russian Federation as an immunostimulant drug has been studied on a series of 53 clinical strains of Mycobacterium tuberculosis (MBT). It is established that tubosan produces a bactericidal effect on drug-sensitive MBT strains and a bacteriostatic effect on resistant MBT strains. Use of tubosan for the treatment of 102 patients with drug-resistant destructive tuberculosis showed evident clinical-radiological involution process, with prospects of clinical recovery for 75% of patients. Results of this study show that tubosan possesses both antituberculosis and immunostimulant properties. It is recommended to use tubosan for complex treatment of patients with drug-resistant tuberculosis. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|